Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Mar 15;104(6):1007-12.
doi: 10.1038/bjc.2011.33. Epub 2011 Feb 22.

Expression of osteopontin coregulators in primary colorectal cancer and associated liver metastases

D J Mole  1 , C O'Neill, P Hamilton, B Olabi, V Robinson, L Williams, T Diamond, M El-Tanani, F C Campbell
Affiliations

Expression of osteopontin coregulators in primary colorectal cancer and associated liver metastases

D J Mole et al. Br J Cancer. .

Abstract

Background: A transcription regulatory complex (TRC) that includes Ets1, Ets2, PEA3 and β-catenin/T-cell factors regulates osteopontin (OPN) that is implicated in colorectal cancer (CRC) dissemination. The consistency of OPN transcriptional control between primary CRC and metastases is unclear. This study investigates expression and prognostic significance of the OPN-TRC in primary human CRC and associated colorectal liver metastases (CRLM).

Methods: Osteopontin-TRC factors were assayed by digital microscopy in 38 primary CRCs and matched CRLM specimens and assessed against clinical prognosis.

Results: In primary CRC, OPN expression intensity correlated with that of its co-activators, PEA3 (r=0.600; P<0.01), Ets1 (r=0.552; P<0.01), Ets2 (r=0.521; P<0.01) and had prognostic significance. Osteopontin intensity in primary CRC inversely correlated with the interval between diagnosis and resection of CRLM. Overall OPN intensity was lower in CRLM than primary CRC and correlations with co-activators were weaker, for example, Ets1 (P=0.047), PEA3 (P=0.022) or nonsignificant (Ets2). The ratio of OPN expression in CRLM vs primary CRC had prognostic significance.

Conclusion: This study supports transcriptional control of OPN by known coregulators in both primary and secondary CRC. Weaker associations in CRLM suggest involvement of other unknown factors possibly from the liver microenvironment or resulting from additional genetic or epigenetic changes that drive tumour metastatic capability in OPN transcriptional control.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Digital expression analysis of OPN. An automated positive pixel count algorithm was applied to the digitally scanned annotated images. The image shown is a section of colorectal primary tumour stained for OPN visualised with DAB.
Figure 2
Figure 2
Osteopontin and coregulators in primary CRC and CRLM matched pairs. Consecutive sections of colorectal primary tumour and liver metastasis, illustrating the raw scanned image and the positive pixel count for each primary antibody. Line diagrams show the difference between primary tumour and matched liver metastasis for each patient.
Figure 3
Figure 3
Osteopontin intensity in primary CRC vs interval to liver resection. Osteopontin expression in primary CRC inversely correlates with interval between colectomy and liver resection for metastases (P=0.045; Pearson's product moment test).
See this image and copyright information in PMC

References

    1. Agrawal D, Chen T, Irby R, Quackenbush J, Chambers AF, Szabo M, Cantor A, Coppola D, Yeatman TJ (2002) Osteopontin identified as lead marker of colon cancer progression, using pooled sample expression profiling. J Natl Cancer Inst 94: 513–521 - PubMed
    1. Costello SS, Johnston DJ, Dervan PA, O’Shea DG (2003) Development and evaluation of the virtual pathology slide: a new tool in telepathology. J Med Internet Res 5: e11. - PMC - PubMed
    1. El-Tanani M, Platt-Higgins A, Rudland PS, Campbell FC (2004) Ets gene PEA3 cooperates with beta-catenin-Lef-1 and c-Jun in regulation of osteopontin transcription. J Biol Chem 279: 20794–20806 - PubMed
    1. El-Tanani MK, Campbell FC, Kurisetty V, Jin D, McCann M, Rudland PS (2006) The regulation and role of osteopontin in malignant transformation and cancer. Cytokine Growth Factor Rev 17: 463–474 - PubMed
    1. El-Tanani MK, Jin D, Campbell FC, Johnston PG (2010) Interferon-induced transmembrane 3 binds osteopontin in vitro: expressed in vivo IFITM3 reduced OPN expression. Oncogene 29: 752–762 - PubMed

Publication types

MeSH terms

Substances